Latest Insurance News

Aeeris Ltd reported a profitable quarter with 13% revenue growth and launched its proprietary AWARE system, while navigating the departure of its founder and CEO.

Challenger Limited reported a robust 9% rise in normalised net profit after tax to $456 million for FY25, alongside an 11% dividend increase, while welcoming APRA's capital reforms that promise to boost its financial resilience and growth in retirement income products.

Hiremii Limited reported a 6% revenue increase and an 18% rise in gross profit for Q1 FY26, driven by global job board integration and a successful capital raise to fuel its AI-powered recruitment platform.

icetana Limited posted a net operating cash outflow of AUD 1.126 million for the quarter ending September 2025, ending with a cash balance of AUD 2.71 million. The company’s cash runway currently covers approximately one quarter based on existing cash flows.

Spectur Limited reported a strategic revenue shift in Q1 FY26, with SaaS recurring revenue growing 5% year-on-year despite an overall 9% quarterly revenue dip. The company also raised $2.3 million to accelerate its solar-powered AI platform development.

Challenger Limited has welcomed APRA’s proposed capital standards for longevity products, highlighting their potential to reduce capital requirements and stimulate growth in Australia’s retirement income sector.

Helia Group’s 3Q25 APRA data reveals rising gross written premiums despite government scheme pressures, while a Board review confirms strategic focus on the Australian LMI market with significant cost cuts.

Medibank has set ambitious goals to triple its health segment earnings by FY30, expand its private health insurance market share, and double its health engagement, signaling a strategic pivot towards integrated, technology-driven care.

Neurotech International has initiated an Authorised Prescriber program for its lead therapy NTI164, expanding access for children with neurodevelopmental disorders in Australia. The company also secured a Rare Pediatric Disease Designation from the US FDA for NTI164 in Rett Syndrome, marking a key regulatory milestone.

AUB Group has received a revised $45 per share acquisition proposal from EQT, prompting the board to grant exclusivity for due diligence. The deal remains non-binding and subject to multiple conditions.

Whitefield Industrials reports a $10.5 million net profit for H1 2026, with a strong 17.1% annualised return over three years, maintaining its track record of benchmark outperformance and announcing a 10.5 cent fully franked dividend.

Emyria reports strong revenue growth driven by expanded insurer-funded mental health programs, marking a significant step in national access to evidence-based PTSD and treatment-resistant depression care.